Description
Sermorelin Acetate is the acetate salt of a 29-residue peptide reproducing the bioactive N-terminal portion of growth hormone-releasing hormone. It acts as a GHRH receptor agonist and is used to model endogenous GHRH signaling in controlled studies.
Investigations have centered on pituitary somatotroph activity, growth hormone release kinetics, and IGF-1 axis responses across in vitro preparations and rodent systems. Its truncated, well-defined sequence makes it a convenient reference point for GHRH-pathway research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.